Adjuvant sequential methotrexate → 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer

por Sobrero, A, Frassineti, G, Falcone, A, Dogliotti, L, Rosso, R, Di Costanzo, F, Bruzzi, P
Publicado 2005

Adjuvant sequential methotrexate → 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer

por Sobrero, A, Frassineti, G, Falcone, A, Dogliotti, L, Rosso, R, Costanzo, F D, Bruzzi, P
Publicado 2005

Primary Cardiac Angiosarcoma: A Fatal Disease

por Antonuzzo, L., Rotella, V., Mazzoni, F., Doni, L., Bianchini, D., Garbini, F., Maio, V., Di Costanzo, F.
Publicado 2009

Biological Characteristics and Medical Treatment of Breast Cancer in Young Women—A Featured Population: Results from the NORA Study

por Pronzato, P., Mustacchi, G., De Matteis, A., Di Costanzo, F., Rulli, E., Floriani, I., Cazzaniga, M. E.
Publicado 2011

Gemcitabine with or without continuous infusion 5-FU in advanced pancreatic cancer: a randomised phase II trial of the Italian oncology group for clinical research (GOIRC)

por Di Costanzo, F, Carlini, P, Doni, L, Massidda, B, Mattioli, R, Iop, A, Barletta, E, Moscetti, L, Recchia, F, Tralongo, P, Gasperoni, S
Publicado 2005

BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells

por Tassone, P, Tagliaferri, P, Perricelli, A, Blotta, S, Quaresima, B, Martelli, M L, Goel, A, Barbieri, V, Costanzo, F, Boland, C R, Venuta, S
Publicado 2003

Epithelial-to-mesenchymal transition in FHC-silenced cells: the role of CXCR4/CXCL12 axis

por Aversa, I., Zolea, F., Ieranò, C., Bulotta, S., Trotta, A. M., Faniello, M. C., De Marco, C., Malanga, D., Biamonte, F., Viglietto, G., Cuda, G., Scala, S., Costanzo, F.
Publicado 2017

Phylloporus and Phylloboletellus are no longer alone: Phylloporopsis gen. nov. (Boletaceae), a new smooth-spored lamellate genus to accommodate the American species Phylloporus bol...

por Farid, A., Gelardi, M., Angelini, C., Franck, A.R., Costanzo, F., Kaminsky, L., Ercole, E., Baroni, T.J., White, A.L., Garey, J.R., Smith, M.E., Vizzini, A.
Publicado 2018

Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB–IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial tr...

por Boni, C, Tiseo, M, Boni, L, Baldini, E, Recchia, F, Barone, C, Grossi, F, Germano, D, Matano, E, Marini, G, Labianca, R, Di Costanzo, F, Bagnulo, A, Pennucci, C, Caroti, C, Mencoboni, M, Zanelli, F, Prochilo, T, Cafferata, M A, Ardizzoni, A
Publicado 2012

hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma

por Lastraioli, E, Perrone, G, Sette, A, Fiore, A, Crociani, O, Manoli, S, D'Amico, M, Masselli, M, Iorio, J, Callea, M, Borzomati, D, Nappo, G, Bartolozzi, F, Santini, D, Bencini, L, Farsi, M, Boni, L, Di Costanzo, F, Schwab, A, Onetti Muda, A, Coppola, R, Arcangeli, A
Publicado 2015